ES532802A0 - Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol - Google Patents

Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol

Info

Publication number
ES532802A0
ES532802A0 ES532802A ES532802A ES532802A0 ES 532802 A0 ES532802 A0 ES 532802A0 ES 532802 A ES532802 A ES 532802A ES 532802 A ES532802 A ES 532802A ES 532802 A0 ES532802 A0 ES 532802A0
Authority
ES
Spain
Prior art keywords
hidroxibutoxi
butanol
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES532802A
Other languages
English (en)
Spanish (es)
Other versions
ES8507449A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Luso Farmaco dItalia SpA
Original Assignee
Istituto Luso Farmaco dItalia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Luso Farmaco dItalia SpA filed Critical Istituto Luso Farmaco dItalia SpA
Publication of ES8507449A1 publication Critical patent/ES8507449A1/es
Publication of ES532802A0 publication Critical patent/ES532802A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/132—Saturated ethers containing hydroxy or O-metal groups both carbon chains being substituted by hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/164—Unsaturated ethers containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES532802A 1983-05-30 1984-05-25 Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol Granted ES532802A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21352/83A IT1164254B (it) 1983-05-30 1983-05-30 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione

Publications (2)

Publication Number Publication Date
ES8507449A1 ES8507449A1 (es) 1985-10-01
ES532802A0 true ES532802A0 (es) 1985-10-01

Family

ID=11180528

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532802A Granted ES532802A0 (es) 1983-05-30 1984-05-25 Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol

Country Status (8)

Country Link
US (1) US4584321A (en, 2012)
JP (1) JPS604146A (en, 2012)
BE (1) BE899790A (en, 2012)
DE (1) DE3419947A1 (en, 2012)
ES (1) ES532802A0 (en, 2012)
FR (1) FR2547813B1 (en, 2012)
GB (1) GB2142623B (en, 2012)
IT (1) IT1164254B (en, 2012)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541129A (ja) * 1999-04-01 2002-12-03 エスペリオン セラピューティクス インコーポレイテッド エーテル化合物、組成物、およびそれらの使用
CN101426763A (zh) 2000-10-11 2009-05-06 埃斯佩里安医疗公司 用于胆固醇治疗和相关应用的硫化物和二硫化物化合物和组合物
CA2425311C (en) 2000-10-11 2011-06-14 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
EP1366024A2 (en) 2000-10-11 2003-12-03 Esperion Therapeutics Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
MXPA03003021A (es) 2000-10-11 2003-07-14 Esperion Therapeutics Inc Compuestos de eter y composiciones para el control del colesterol y usos relacionados.
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
AU2003230918A1 (en) * 2002-04-10 2003-10-27 Esperion Therapeutics, Inc. Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
MX349134B (es) 2003-01-23 2017-07-12 Esperion Therapeutics Inc Compuestos de hidroxilo y composiciones para el manejo del colesterol y usos relacionados.
CA2549995C (en) 2003-12-24 2011-11-15 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
CN103848726B (zh) * 2012-12-09 2017-09-05 河北凯盛医药科技有限公司 一种高纯度二羟二丁基醚及其制备方法
CN103304383B (zh) * 2013-06-18 2015-04-08 重庆医科大学 保胆健素的新合成方法
CN103319316B (zh) * 2013-06-24 2015-06-10 大连理工大学 一种二羟基二丁醚的绿色制备方法
CN103333057A (zh) * 2013-06-24 2013-10-02 大连理工大学 一种二羟基二丁醚的制备方法
CN104230674A (zh) * 2014-08-28 2014-12-24 成都邦泽生物医药科技有限公司 一种二羟基二丁醚的制备方法
US10912751B2 (en) 2015-03-13 2021-02-09 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
MX2021015935A (es) 2019-06-21 2022-04-26 Esperion Therapeutics Inc Formas de sal de acido bempedoico y metodos para utilizar el mismo.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT957008B (it) * 1967-11-09 1973-10-10 Luso Farmaco Inst Processo per la preparazione di eteri simmetrici di glicoli re canti ossidrili primari e secon dari
DE2218935C3 (de) * 1972-04-19 1980-01-31 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von wäßrigen Lösungen von N-Vinylpyrrolidonpolymerisaten

Also Published As

Publication number Publication date
ES8507449A1 (es) 1985-10-01
DE3419947C2 (en, 2012) 1987-11-26
IT8321352A0 (it) 1983-05-30
DE3419947A1 (de) 1984-12-06
GB8411356D0 (en) 1984-06-06
FR2547813B1 (fr) 1989-01-27
IT1164254B (it) 1987-04-08
BE899790A (fr) 1984-11-30
JPS604146A (ja) 1985-01-10
JPS6241702B2 (en, 2012) 1987-09-04
GB2142623A (en) 1985-01-23
GB2142623B (en) 1987-04-15
IT8321352A1 (it) 1984-11-30
US4584321A (en) 1986-04-22
FR2547813A1 (fr) 1984-12-28

Similar Documents

Publication Publication Date Title
ES501130A0 (es) Procedimiento de obtencion de mucopolisacaridos
ES532802A0 (es) Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol
RO82162A (ro) Procedeu pentru prepararea unor aminotiadiazoli
RO81652A (ro) Procedeu pentru pentru prepararea unor benzimidazoazepine
RO82214A (ro) Procedeu pentru prepararea unor pirimodone
ES502747A0 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
RO86511A (ro) Procedeu pentru prepararea unor beta-lactame
FI832726A7 (fi) Halogeneringsfoerfarande
ES536780A0 (es) Procedimiento de preparar nuevas bencensulfonil-lactamas
AR229026A1 (es) Procedimiento de preparacion de amino-alquil-dibenzo-oxepinas sustituidas
RO84099A (ro) Procedeu pentru obtinerea 1,2,5-o0adiazol-2-o0izilor
MX155064A (es) Procedimiento de preparacion de metafenilendiaminas
ES526910A0 (es) Procedimiento de producir alquilangelicinas
ES536488A0 (es) Procedimiento de obtencion de 6-metil-19-nor-pregna 4, 6 dieno 3, 20-dionas
FI834289A0 (fi) Medbringare foer en draganordning
ES533691A0 (es) Procedimiento de preparar 2,9-dihidrofuranos
NO833669L (no) Fremgangsmaate for elektroplettering
ES502465A0 (es) Procedimiento de preparar nuevas triazoloquinoxalin-1,4-dio-nas antialergicas
ES525995A0 (es) Procedimiento de obtencion de piridopirimidinonas
ES523350A0 (es) Procedimiento de obtencion de las (feniloxoalcoil) piperidinoguanidinas
RO81684A (ro) Procedeu pentru prepararea unor benzolamine
ES497763A0 (es) Procedimiento de obtencion de nuevos 2-aminoetanoles
IT8249202A0 (it) Procedimento per produrre poliesterpolicarbonato
RO89014A (ro) Procedeu pentru obtinerea ferocromului
ES504202A0 (es) Procedimiento de obtencion de benzhidrilpiperazinas